Trial · NCT02900729

Randomized Controlled Trial of Renal Denervation for Resistant Hypertension

NCT02900729, Phase 3, Unknown, Shanghai WiseGain Medical Devices Co., Ltd.

3 sourcestrials-2026-11-12-0.5.0

Cite this record

ConductScience Library. Randomized Controlled Trial of Renal Denervation for Resistant Hypertension. Trials, record NCT02900729. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02900729

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title: Randomized Controlled Trial of Renal Denervation for Resistant Hypertension
NCT number: NCT02900729
Status: Unknown
Phases: Phase 3
Enrollment: 254 participants, estimated
Lead sponsor: Shanghai WiseGain Medical Devices Co., Ltd.
Conditions: Hypertension
Interventions: Radiofrequency ablation catheter, Amlodipine, losartan potassium and hydrochlorothiazide
First posted: 2016-09-14
Last updated: 2016-09-14

Source ClinicalTrials.gov

Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

List	Outcome	Time frame	Description
Primary	Change in average 24-hour systolic blood pressure by ambulatory blood pressure monitoring from baseline	3 months post-randomization
Secondary	Incidence of achieving target blood pressure	6 months post-randomization	Target blood pressure is defined as daytime ambulatory blood pressure \<135/85mmHg, nighttime ambulatory blood pressure \<120/70mmHg or average 24-hour ambulatory blood pressure \<130/80mmHg, respectively
Secondary	Change in daytime and nighttime ambulatory systolic blood pressure from baseline	3 months post-randomization
Secondary	Change in 24 hour average, daytime and nighttime ambulatory diastolic blood pressure from baseline	3 months post-randomization
Secondary	Change in serum creatinine from baseline	6 months post-randomization
Secondary	Incidence of adverse event	Through study completion, up to 6 months
Other	Change in 24 hour average, daytime and nighttime ambulatory systolic/diastolic blood pressure from baseline	6 months post-randomization
Other	Change in office systolic/diastolic blood pressure from baseline	6 months post-randomization
Other	Change in patient-recorded home systolic/diastolic blood pressure from baseline	6 months post-randomization
Other	Incidences of achieving reductions of ≥ 5 mmHg, ≥ 10 mmHg, ≥15 mmHg, and ≥ 20 mmHg in blood pressure, including ambulatory, office and home blood pressure	6 months post-randomization

1 to 10 of 11Source ClinicalTrials.gov

See all 11 registered outcomes

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers2

The papers the trial lists on ClinicalTrials.gov.

PMID	Listed as	Source
24678939	BACKGROUND	PubMed
28864691	DERIVED	PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov: 2026-11-12; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
NIH grant links: 2026-11-13; NIH RePORTER

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02900729

GET https://conductscience.org/api/trials/v1/NCT02900729/registered

API reference For AI assistants